簡易檢索 / 詳目顯示

研究生: 姜俞臣
Jiang, Yu-Chen
論文名稱: 人類血清素受體1A啟動子-480delA突變之功能性分析
Functional Characterization of the -480delA Mutation of Human Serotonin Receptor 1A Gene
指導教授: 孫孝芳
Sun, H. Sunny
學位類別: 碩士
Master
系所名稱: 醫學院 - 分子醫學研究所
Institute of Molecular Medicine
論文出版年: 2010
畢業學年度: 98
語文別: 英文
論文頁數: 47
中文關鍵詞: 血清素受體
外文關鍵詞: serotonin receptor
相關次數: 點閱:74下載:4
分享至:
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報
  • 血清素是人體內主要的神經傳導物質之一,它與許多生理功能的調控有著密不可分的關係,例如:情緒反應、睡眠與體溫調節。當血清素傳遞功能失常時,可能會引發躁鬱症或經前症候群等不同程度的心理及生理問題。血清素受體1A (Serotonin receptor 1A ; HTR1A)已知是血清素傳遞系統中一個重要的自體受體 (autoreceptor) ,先前的研究指出血清素受體1A的功能失調和人類許多疾病,如精神病有關。在一個臨床病例中,有位女性病人其生理期即有反覆性的發燒,其家屬則另有精神性問題、偏頭痛、糖尿病等多種臨床表現。此病人的週期性發燒可藉由buspirone這個藥物有效控制,由於buspirone是血清素受體1A的促效藥,這也暗示了這個病人可能是由於體內缺乏血清素受體1A而造成血清素傳遞功能失常。本研究的目的是去探討血清素受體1A基因與此病人症狀的關係並研究潛在的分子機轉。我們先針對此病人及其家屬的血清素受體1A基因去做突變檢測並發現位於啟動子區的-480delA突變。這結果顯示血清素受體1A啟動子區的-480delA突變可能會改變基因本身與轉錄因子之間的作用進而影響基因的表現及功能。雙重螢光素酶報導基因檢驗(dual-luciferase reporter assay)的結果證實血清素受體1A的-480delA突變的確會降低其基因表現。而凝膠電泳位移測定(Electrophoretic mobility shift assay)也發現有多種轉錄因子可專一性的結合至血清素受體1A的-480啟動子區域。利用biotin pull-down assay及質譜儀分析,我們成功的找出poly(ADP-ribose) polymerase (PARP-1)可能為其中之一的轉錄因子。接著利用染色質免疫沉降法(chromatin immunoprecipitation assay)更進一步的確認了PARP-1與血清素受體1A啟動子之間的結合能力。此外,過度及降低PARP-1在細胞中的表現都相對影響血清素受體1A的表現量,因此證實PARP-1扮演血清素受體1A基因表現的抑制蛋白的角色。綜合以上結果,我們發現血清素受體1A的-480delA突變會導致較多的PARP-1結合至啟動子區,進而造成較明顯的基因抑制效果。而血清素受體1A基因的表現一旦減少可能會使得其在調節降低體溫的功能失衡,而造成我們所觀察到的臨床症狀。由於血清素受體1A是血清素傳遞過程重要的自體受體,與調節細胞間血清素的量及維持血清素傳遞平衡有關,本研究結果將是研究血清素相關疾病病理機制的珍貴資訊。

    Serotonin (5-hydroxytryptamine) is one of the key neurotransmitters that involves in the regulation of many important physiological conditions, such as mood and thermoregulation. Dysfunction of serotonergic transmission has been implicated in the pathogenesis of many diseases, for example, bipolar disorder and premenstrual syndrome. Serotonin receptor 1A (HTR1A) is one of the autoreceptors for serotonin transmission. Dysfunction of HTR1A has been found to be associated with many human diseases such as psychosis. In clinic, we identified one 33-year-old female with periodic menstrual fever responded well to buspirone, a HTR1A agonist, it suggested that her periodic menstrual fever was highly correlated with HTR1A deficiency. This study aimed to illustrate the molecular mechanisms underlying the clinical observation in this patient. We thoroughly screened HTR1A sequences and identified the -480delA mutation in the promoter region in this patient. We hypothesized that HTR1A -480delA mutation may be responsible for the observed clinical phenotype through the interaction with nuclear factor to impair HTR1A function. Interestingly, dual-luciferase reporter assays also revealed that HTR1A -480delA mutation decreases reporter gene activity. Using biotinylated DNA probe, electrophoretic mobility shift assay (EMSA), and competition assay showed that multiple nuclear proteins specifically bind to this sequence motif. Followed by biotin pull-down assay and LC-MS-MS analysis, we successfully identified poly(ADP-ribose) polymerase (PARP-1) as one of the potential candidates that binds to HTR1A promoter motif. The DNA-protein interaction was further confirmed by chromatin immunoprecipitation (ChIP) assay. Overexpression and knockdown of PARP-1 result in suppressed and enhanced expression of HTR1A, respectively. These data suggested that PARP-1 functions as a repressor of HTR1A expression. Furthermore, HTR1A -480delA mutation causes an increased interaction between PARP-1 and HTR1A, and consequently, results in a further reduction of HTR1A expression. Reduction of expression of HTR1A may thus disrupt HTR1A-mediated hypothermic responses and cause the phenotype we observed in the clinical case. Since HTR1A is an important autoreceptor for serotonin transmission, results from our study will provide valuable information for the role of HTR1A in serotonin-related diseases.

    摘要 I Abstract III 誌謝 V Table of contents VII List of table IX List of figures X 1.Introduction 1 1.1. Serotonin 1 1.1.1. The biological function of serotonin 1 1.1.2. Serotonin related diseases 1 1.2. Serotonin receptor 1A (HTR1A) 2 1.2.1. Serotonin receptors 2 1.2.2. Serotonin receptor 1A 3 1.2.3. Biological function of HTR1A 3 1.2.4. Genetics studies of HTR1A 4 1.3. Controls of gene expression in Eukaryotes 5 1.3.1. Mechanisms controlling gene expression 5 1.3.2. Regulation of gene expression in the 5’ promoter region 5 1.3.3. Transcription factors 6 1.4. A clinical case report 6 1.4.1. Clinical phenotype 6 1.4.2. Mutation screening of HTR1A in the proband and her family members ……………………………………………………………………7 1.5. Objective of this study 7 2.Materials and methods 9 2.1. Cell line and constructs 9 2.2. Transcription factor binding site prediction 10 2.3. Transient transfection and dual luciferase assay 10 2.4. Nuclear extract preparation 10 2.5. Electrophoretic mobility shift assay (EMSA) 11 2.6. Biotin pull down assay 12 2.7. Silver stain 12 2.8. Antibodies 13 2.9. Western blot 13 2.10. Chromatin immunoprecipitation (ChIP) assay 13 2.11. Real-time qPCR 14 2.12. RNA interference 15 2.13. Statistical analysis 15 3.Results 16 3.1. The wild-type HTR1A promoter shows higher luciferase activity than the mutant HTR1A sequences 16 3.2. HTR1A promoter region is bound by specific nuclear proteins 16 3.3. Glucocorticoid receptor (GR) was suggested to interact with HTR1A promoter by bioinformatics tools 17 3.4. Poly(ADP-ribose) polymerase 1 (PARP-1) was identified as a potential HTR1A promoter binding protein by biological strategy 18 3.5. PARP-1 bound to both wild-type and mutant HTR1A promoters 18 3.6. HTR1A -480delA mutation caused an increased interaction between PARP-1 and HTR1A 19 3.7. PARP-1 is a negative regulator of HTR1A expression 20 4.Discussions 22 4.1. Significance of mutations in the promoter region 22 4.1.1. Promoter mutations and human diseases 22 4.1.2. -480delA mutation of HTR1A gene 22 4.2. Overview of poly(ADP-ribose) polymerase (PARP) family protein 23 4.2.1. PARP-1 structure and function 24 4.2.2. Modulation of chromatin structure by PARP-1 24 4.2.3. Enhancer-binding actions of PARP-1 25 4.2.4. Transcriptional coregulation by PARP-1 25 4.2.5. Insulator functions of PARP-1 26 4.3. The effect of PARP-3 on gene regulation 27 4.4. The correlation between HTR1A -480delA mutation and clinical observation …………………………………………………………………………..28 5.Conclusion 30 6.Reference 42

    Abdel-Fattah, A. F., K. Matsumoto, et al. (1995). "5-HT1A and 5-HT2 receptors mediate hypo- and hyperthermic effects of tryptophan in pargyline-pretreated rats." Pharmacol Biochem Behav 52(2): 379-384.
    Abdel-Fattah, A. F., K. Matsumoto, et al. (1997). "Central serotonin level-dependent changes in body temperature following administration of tryptophan to pargyline- and harmaline-pretreated rats." Gen Pharmacol 28(3): 405-409.
    Albert, P. R., Q. Y. Zhou, et al. (1990). "Cloning, functional expression, and mRNA tissue distribution of the rat 5-hydroxytryptamine1A receptor gene." J Biol Chem 265(10): 5825-5832.
    Althaus, F. R. and C. Richter (1987). "ADP-ribosylation of proteins. Enzymology and biological significance." Mol Biol Biochem Biophys 37: 1-237.
    Ambrose, H. E., V. Papadopoulou, et al. (2007). "Poly-(ADP-ribose) polymerase-1 (Parp-1) binds in a sequence-specific manner at the Bcl-6 locus and contributes to the regulation of Bcl-6 transcription." Oncogene 26(42): 6244-6252.
    Ame, J. C., C. Spenlehauer, et al. (2004). "The PARP superfamily." Bioessays 26(8): 882-893.
    Augustin, A., C. Spenlehauer, et al. (2003). "PARP-3 localizes preferentially to the daughter centriole and interferes with the G1/S cell cycle progression." J Cell Sci 116(Pt 8): 1551-1562.
    Azmitia, E. C., P. J. Gannon, et al. (1996). "Cellular localization of the 5-HT1A receptor in primate brain neurons and glial cells." Neuropsychopharmacology 14(1): 35-46.
    Barnes, N. M. and T. Sharp (1999). "A review of central 5-HT receptors and their function." Neuropharmacology 38(8): 1083-1152.
    Bell, A. C. and G. Felsenfeld (2000). "Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene." Nature 405(6785): 482-485.
    Bockaert, J., S. Claeysen, et al. (2006). "Neuronal 5-HT metabotropic receptors: fine-tuning of their structure, signaling, and roles in synaptic modulation." Cell Tissue Res 326(2): 553-572.
    Breen, T. R. and I. M. Duncan (1986). "Maternal expression of genes that regulate the bithorax complex of Drosophila melanogaster." Dev Biol 118(2): 442-456.
    Brivanlou, A. H. and J. E. Darnell, Jr. (2002). "Signal transduction and the control of gene expression." Science 295(5556): 813-818.
    Celada, P., M. V. Puig, et al. (2001). "Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: Involvement of serotonin-1A, GABA(A), and glutamate receptors." J Neurosci 21(24): 9917-9929.
    Cohen, I. R. and P. M. Wise (1988). "Effects of estradiol on the diurnal rhythm of serotonin activity in microdissected brain areas of ovariectomized rats." Endocrinology 122(6): 2619-2625.
    Cooper, D. N. (2002). "Human gene mutation in pathology and evolution." J Inherit Metab Dis 25(3): 157-182.
    Dai, S., Z. Wang, et al. (2010). "Functional analysis of promoter mutations in the ACTN4 and SYNPO genes in focal segmental glomerulosclerosis." Nephrol Dial Transplant 25(3): 824-835.
    Davidson, E. H. (2006). The Regulatory Genome: Gene Regulatory Networks In Development And Evolution New York, Academic Press.
    Dhingra, V., J. L. Magnay, et al. (2007). "Serotonin receptor 1A C(-1019)G polymorphism associated with premenstrual dysphoric disorder." Obstet Gynecol 110(4): 788-792.
    Eaton, M. J., J. K. Staley, et al. (1995). "Developmental regulation of early serotonergic neuronal differentiation: the role of brain-derived neurotrophic factor and membrane depolarization." Dev Biol 170(1): 169-182.
    Fakra, E., L. W. Hyde, et al. (2009). "Effects of HTR1A C(-1019)G on amygdala reactivity and trait anxiety." Arch Gen Psychiatry 66(1): 33-40.
    Fargin, A., J. R. Raymond, et al. (1988). "The genomic clone G-21 which resembles a beta-adrenergic receptor sequence encodes the 5-HT1A receptor." Nature 335(6188): 358-360.
    Gasperikova, D., N. D. Tribble, et al. (2009). "Identification of a novel beta-cell glucokinase (GCK) promoter mutation (-71G>C) that modulates GCK gene expression through loss of allele-specific Sp1 binding causing mild fasting hyperglycemia in humans." Diabetes 58(8): 1929-1935.
    Gross, C., X. Zhuang, et al. (2002). "Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult." Nature 416(6879): 396-400.
    Hassa, P. O., C. Buerki, et al. (2003). "Transcriptional coactivation of nuclear factor-kappaB-dependent gene expression by p300 is regulated by poly(ADP)-ribose polymerase-1." J Biol Chem 278(46): 45145-45153.
    Hassa, P. O. and M. O. Hottiger (2002). "The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NF-kappaB in inflammatory disorders." Cell Mol Life Sci 59(9): 1534-1553.
    Heitz, N. A., P. A. Eisenman, et al. (1999). "Hormonal Changes Throughout the Menstrual Cycle and Increased Anterior Cruciate Ligament Laxity in Females." J Athl Train 34(2): 144-149.
    Heller, H. and E. Bengal (1998). "TFIID (TBP) stabilizes the binding of MyoD to its DNA site at the promoter and MyoD facilitates the association of TFIIB with the preinitiation complex." Nucleic Acids Res 26(9): 2112-2119.
    Hornung, J. P. (2003). "The human raphe nuclei and the serotonergic system." J Chem Neuroanat 26(4): 331-343.
    Huang, Y. Y., C. Battistuzzi, et al. (2004). "Human 5-HT1A receptor C(-1019)G polymorphism and psychopathology." Int J Neuropsychopharmacol 7(4): 441-451.
    Inayama, Y., H. Yoneda, et al. (1996). "Positive association between a DNA sequence variant in the serotonin 2A receptor gene and schizophrenia." Am J Med Genet 67(1): 103-105.
    Jacobs, B. L. and E. C. Azmitia (1992). "Structure and function of the brain serotonin system." Physiol Rev 72(1): 165-229.
    Ju, B. G., V. V. Lunyak, et al. (2006). "A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription." Science 312(5781): 1798-1802.
    Kawanishi, Y., S. Harada, et al. (1998). "Novel mutations in the promoter and coding region of the human 5-HT1A receptor gene and association analysis in schizophrenia." Am J Med Genet 81(5): 434-439.
    Kim, M. Y., T. Zhang, et al. (2005). "Poly(ADP-ribosyl)ation by PARP-1: 'PAR-laying' NAD+ into a nuclear signal." Genes Dev 19(17): 1951-1967.
    Kraus, W. L. and J. T. Lis (2003). "PARP goes transcription." Cell 113(6): 677-683.
    Krishnakumar, R., M. J. Gamble, et al. (2008). "Reciprocal binding of PARP-1 and histone H1 at promoters specifies transcriptional outcomes." Science 319(5864): 819-821.
    Kusserow, H., B. Davies, et al. (2004). "Reduced anxiety-related behaviour in transgenic mice overexpressing serotonin 1A receptors." Brain Res Mol Brain Res 129(1-2): 104-116.
    Lazebnik, Y. A., S. H. Kaufmann, et al. (1994). "Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE." Nature 371(6495): 346-347.
    Le Francois, B., M. Czesak, et al. (2008). "Transcriptional regulation at a HTR1A polymorphism associated with mental illness." Neuropharmacology 55(6): 977-985.
    Lesch, K. P. and L. Gutknecht (2004). "Focus on The 5-HT1A receptor: emerging role of a gene regulatory variant in psychopathology and pharmacogenetics." Int J Neuropsychopharmacol 7(4): 381-385.
    Lewin, B. (2008). Genes IX. United states of America, Jones and Bartlett.
    Lin, Y. M., S. C. Chao, et al. (2007). "Association of functional polymorphisms of the human tryptophan hydroxylase 2 gene with risk for bipolar disorder in Han Chinese." Arch Gen Psychiatry 64(9): 1015-1024.
    Lobe, C. G. (1992). "Transcription factors and mammalian development." Curr Top Dev Biol 27: 351-383.
    Lundell, M. J., Q. Chu-LaGraff, et al. (1996). "The engrailed and huckebein genes are essential for development of serotonin neurons in the Drosophila CNS." Mol Cell Neurosci 7(1): 46-61.
    Majewski, J. and J. Ott (2002). "Distribution and characterization of regulatory elements in the human genome." Genome Res 12(12): 1827-1836.
    Mann, J. J., K. M. Malone, et al. (1996). "Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients." Am J Psychiatry 153(2): 174-182.
    Marazziti, D., A. Lenzi, et al. (1991). "Serotoninergic dysfunction in bipolar disorder." Pharmacopsychiatry 24(5): 164-167.
    Maston, G. A., S. K. Evans, et al. (2006). "Transcriptional regulatory elements in the human genome." Annu Rev Genomics Hum Genet 7: 29-59.
    Matsui, T., J. Segall, et al. (1980). "Multiple factors required for accurate initiation of transcription by purified RNA polymerase II." J Biol Chem 255(24): 11992-11996.
    McNatty, K. P., W. M. Hunter, et al. (1975). "Changes in the concentration of pituitary and steroid hormones in the follicular fluid of human graafian follicles throughout the menstrual cycle." J Endocrinol 64(3): 555-571.
    Mitchell, E. S. and J. F. Neumaier (2005). "5-HT6 receptors: a novel target for cognitive enhancement." Pharmacol Ther 108(3): 320-333.
    Naughton, M., J. B. Mulrooney, et al. (2000). "A review of the role of serotonin receptors in psychiatric disorders." Hum Psychopharmacol 15(6): 397-415.
    Oei, S. L., J. Griesenbeck, et al. (1998). "Regulation of RNA polymerase II-dependent transcription by poly(ADP-ribosyl)ation of transcription factors." J Biol Chem 273(48): 31644-31647.
    Ogryzko, V. V., R. L. Schiltz, et al. (1996). "The transcriptional coactivators p300 and CBP are histone acetyltransferases." Cell 87(5): 953-959.
    Olabisi, O. A., N. Soto-Nieves, et al. (2008). "Regulation of transcription factor NFAT by ADP-ribosylation." Mol Cell Biol 28(9): 2860-2871.
    Ottolenghi, C., M. Uda, et al. (2007). "Determination and stability of sex." Bioessays 29(1): 15-25.
    Parks, C. L. and T. Shenk (1996). "The serotonin 1a receptor gene contains a TATA-less promoter that responds to MAZ and Sp1." J Biol Chem 271(8): 4417-4430.
    Pavri, R., B. Lewis, et al. (2005). "PARP-1 determines specificity in a retinoid signaling pathway via direct modulation of mediator." Mol Cell 18(1): 83-96.
    Pazos, A. and J. M. Palacios (1985). "Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors." Brain Res 346(2): 205-230.
    Preisig, M., F. Ferrero, et al. (2005). "Monoamine oxidase a and tryptophan hydroxylase gene polymorphisms: are they associated with bipolar disorder?" Am J Pharmacogenomics 5(1): 45-52.
    Ramboz, S., R. Oosting, et al. (1998). "Serotonin receptor 1A knockout: an animal model of anxiety-related disorder." Proc Natl Acad Sci U S A 95(24): 14476-14481.
    Rapport, M. M., A. A. Green, et al. (1948). "Serum vasoconstrictor, serotonin; isolation and characterization." J Biol Chem 176(3): 1243-1251.
    Reale, A., G. D. Matteis, et al. (2005). "Modulation of DNMT1 activity by ADP-ribose polymers." Oncogene 24(1): 13-19.
    Rouleau, M., D. McDonald, et al. (2007). "PARP-3 associates with polycomb group bodies and with components of the DNA damage repair machinery." J Cell Biochem 100(2): 385-401.
    Simon, J. A. and R. E. Kingston (2009). "Mechanisms of polycomb gene silencing: knowns and unknowns." Nat Rev Mol Cell Biol 10(10): 697-708.
    Stapleton, G., M. P. Somma, et al. (1993). "Cell type-specific interactions of transcription factors with a housekeeping promoter in vivo." Nucleic Acids Res 21(10): 2465-2471.
    Struhl, G. (1981). "A gene product required for correct initiation of segmental determination in Drosophila." Nature 293(5827): 36-41.
    Summer, B. E. and G. Fink (1995). "Estrogen increases the density of 5-hydroxytryptamine(2A) receptors in cerebral cortex and nucleus accumbens in the female rat." J Steroid Biochem Mol Biol 54(1-2): 15-20.
    Tecott, L., S. Shtrom, et al. (1995). "Expression of a serotonin-gated ion channel in embryonic neural and nonneural tissues." Mol Cell Neurosci 6(1): 43-55.
    van Nimwegen, E. (2003). "Scaling laws in the functional content of genomes." Trends Genet 19(9): 479-484.
    Vaquero, A., A. Loyola, et al. (2003). "The constantly changing face of chromatin." Sci Aging Knowledge Environ 2003(14): RE4.
    Veenstra-VanderWeele, J., G. M. Anderson, et al. (2000). "Pharmacogenetics and the serotonin system: initial studies and future directions." Eur J Pharmacol 410(2-3): 165-181.
    Wallace, J. A. and G. Felsenfeld (2007). "We gather together: insulators and genome organization." Curr Opin Genet Dev 17(5): 400-407.
    Wray, G. A., M. W. Hahn, et al. (2003). "The evolution of transcriptional regulation in eukaryotes." Mol Biol Evol 20(9): 1377-1419.
    Xu, L., C. K. Glass, et al. (1999). "Coactivator and corepressor complexes in nuclear receptor function." Curr Opin Genet Dev 9(2): 140-147.
    Young, L. T., J. J. Warsh, et al. (1994). "Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder." Biol Psychiatry 35(2): 121-127.
    Yu, W., V. Ginjala, et al. (2004). "Poly(ADP-ribosyl)ation regulates CTCF-dependent chromatin insulation." Nat Genet 36(10): 1105-1110.
    Zardo, G., A. Reale, et al. (2003). "A role for poly(ADP-ribosyl)ation in DNA methylation." Biochem Cell Biol 81(3): 197-208.
    Zhang, X., R. R. Gainetdinov, et al. (2005). "Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression." Neuron 45(1): 11-16.
    Zhuang, X., C. Gross, et al. (1999). "Altered emotional states in knockout mice lacking 5-HT1A or 5-HT1B receptors." Neuropsychopharmacology 21(2 Suppl): 52S-60S.

    下載圖示 校內:2012-08-18公開
    校外:2012-08-18公開
    QR CODE